Manipal Health Enterprises Ltd

$MANIPALHOSEquityNSEBSE

Manipal Health Enterprises Ltd (MANIPALHOS) last traded at ₹766, a market capitalisation of ₹1,00,738 crore, on a P/E of 114. Over the past 52 weeks the stock has ranged between ₹625 and ₹770. Manipal Health Enterprises Ltd last reported results for the quarter ended Jun 2026, with sales of ₹3,091 crore and net profit of ₹243 crore. Manipal Health Enterprises Ltd’s annual general meeting is scheduled for 29 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Manipal Health Enterprises Ltd share price and key metrics

Current price
₹766
Market cap
₹1,00,738 cr
Stock P/E
114
ROE
12.7%
ROCE
12.1%
Dividend yield
0.00%
52w high / low
770/625

Metrics as of 25 Aug 2026. Not real time.

Manipal Health Enterprises Ltd quarterly results

Manipal Health Enterprises Ltd consolidated quarterly results, figures in ₹ crore
₹ croreJun 2025Mar 2026Jun 2026
Sales2,2382,8823,091
Expenses1,6512,1912,354
Operating profit586691737
OPM %26%24%24%
Other income302759
Interest132289293
Depreciation141185187
Profit before tax344244315
Tax %26%24%23%
Net profit254187243
EPS (₹)2.171.511.96

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Manipal Health Enterprises Ltd annual results

Manipal Health Enterprises Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales1,8133,9754,8066,1728,24210,336
Operating profit3309211,2791,6832,1272,611
OPM %18%23%27%27%26%25%
Net profit-1385424295331,082917
EPS (₹)-20.1271.6356.7370.5027.657.56

TTM is the trailing twelve months to the most recent quarter.

Manipal Health Enterprises Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
42%
3 Years
29%
TTM
25%
Compounded Profit Growth
10 Years
%
5 Years
77%
3 Years
22%
TTM
-10%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
%
1 Year
%
Return on Equity
10 Years
%
5 Years
16%
3 Years
16%
Last Year
13%

Manipal Health Enterprises Ltd shareholding pattern

Manipal Health Enterprises Ltd shareholding pattern by quarter, in percent
% heldAug 2026
Promoters72.08%
FIIs3.66%
DIIs5.20%
Government0.26%
Public18.81%
No. of shareholders3,38,074

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Manipal Health Enterprises Ltd’s AGM?

Manipal Health Enterprises Ltd’s annual general meeting is scheduled for 29 Sept 2026.

  • AGM16th Annual General Meeting to approve financial results, auditor appointment, director re-appointments, and AOA amendments

See the full results calendar for every Indian company reporting in the next 30 days.

Manipal Health Enterprises Ltd corporate filings

  • Audio recording of the Earnings call with Analysts/InvestorCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Manipal Health Enterprises Limited has formally disclosed the audio recording of its…

    Read the full analysis
  • Newspaper extract of the Un-audited Financial Results of the Company for the Quarter June 30, 2026.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Manipal Health Enterprises Limited has formally submitted its un-audited financial…

    Read the full analysis
  • Press release and Investor Presentation for the Earnings Conference Call with Analysts and Investors.Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Manipal Health Enterprises Limited delivered a robust performance in its first quarter as…

    Read the full analysis
  • Board Meeting Outcome for the meeting held on August 20, 2026 For Declaration Of Unaudited Financial Results For The Quarter Ended June 30, 2026.Board Meetingmedium impact
    Filing PDF

    Cruxal's analysis: Manipal Health Enterprises Limited reported consolidated revenue of 3,090.63 crore for…

    Read the full analysis
  • Press release titled " Manipal Health Enterprises to Acquire Kinder Women''s Hospital in Bengaluru".Company Updatemedium impact
    Filing PDF

    Cruxal's analysis: Manipal Health Enterprises has announced the acquisition of Kinder Women's Hospital…

    Read the full analysis
  • Intimation for executing Business Transfer Agreement with Kindorama Healthcare Private Limited.Company Updatemedium impact
    Filing PDF

    Cruxal's analysis: Manipal Health Enterprises Limited has entered into a Business Transfer Agreement to…

    Read the full analysis
  • Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Manipal Health Enterprises has issued an intimation regarding a scheduled…

    Read the full analysis
  • The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August ....Insider Trading / SASTlow impact
    Filing PDF

    Cruxal's analysis: The exchange received a disclosure on August 14, 2026, regarding the reasons for share…

    Read the full analysis
  • The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Manipal Global Health ....Insider Trading / SASThigh impact
    Filing PDF

    Cruxal's analysis: Manipal Health Enterprises Limited has filed a disclosure under SEBI (Substantial…

    Read the full analysis
  • Manipal Health Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/08/2026 ,inter alia, to consider and approve the unaudited financial ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Manipal Health Enterprises Limited has formally intimated the stock exchanges regarding a…

    Read the full analysis
  • The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) LtdInsider Trading / SASThigh impact
    Filing PDF

    Cruxal's analysis: Manipal Health Enterprises Limited has disclosed that promoter group entities, including…

    Read the full analysis
  • The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AGInsider Trading / SASTmedium impact
    Filing PDF

    Cruxal's analysis: Manipal Health Enterprises Limited has disclosed that Deutsche Bank AG, acting as agent…

    Read the full analysis
  • The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Axis Trustee Services LtdInsider Trading / SASTmedium impact
    Filing PDF

    Cruxal's analysis: Manipal Health Enterprises Limited has disclosed that its promoters, Manipal Global…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Manipal Health Enterprises Ltd

Cruxal reads every Manipal Health Enterprises Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Manipal Health Enterprises Ltd (MANIPALHOS) Results, Financials & Share Price | Cruxal